Author

Tahirah Moore

Georgia State University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Approach:experimental assay· 3 Organism:mouse· 2 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Robert M. CoxiD· 3 shared Alexander L. GreningeriD· 2 shared Dariia VyshenskaiD· 2 shared Jenny Wong· 2 shared Richard Karl PlemperiD· 2 shared Alexander LeachiD· 1 shared Andres MeritsiD· 1 shared Carolin M. LieberiD· 1 shared

Activity by Year

2026-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

Robert M. CoxORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Potency of nucleoside analogs against Powassan virus replication and identification of 4'-fluorouridine as a therapeutic candidate for tick-borne orthoflavivirus encephalitis

Devin S. M. Lewis, Tahirah Moore, Ronak Patel, Robert M. Cox

bioRxiv · Sep 25, 2026 · PreprintMicrobiology

Identification and Characterization of Novel Chikungunya Virus Polymerase Inhibitors

Peiqi Yin, Ryan Boyce, Sainan Wang, Michael R. Sirrine, Alexander Leach, Dillon Chu, Dariia Vyshenska, Zafer Şahin, Jenny Wong, Tahirah Moore, Devin Shane M. Lewis, Stephen C. Pelly, Dennis Liotta, Andres Merits, Alexander L. Greninger, , Robert M. Cox

This study identifies novel small-molecule inhibitors of Chikungunya virus replication through high-throughput screening and characterizes their mechanism of action and resistance profiles.

Journal of Virology · May 19, 2026Peer-reviewedMolecular Biology

Impact of Mutations Affecting 4'-Fluorouridine Susceptibility on Fitness and Treatment Outcomes for Venezuelan Equine Encephalitis Virus

Jenny Wong, Tahirah Moore, Devin Lewis, Carolin M. Lieber, Dariia Vyshenska, Elizabeth B. Sobolik, Sarah Zimmermann, George R. Painter, Richard Karl Plemper, Alexander L. Greninger, Robert M. Cox

This study identifies mutations in VEEV nsP4 that reduce susceptibility to 4-FlU, shows these mutations do not fully prevent 4-FlU's therapeutic effect in mice, and highlights its potential as an antiviral for alphavirus encephalitis.

Journal of Virology · Jan 15, 2026Peer-reviewedMicrobiology